1. Catalona WJ, Basler JW. Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. J Urol 1993;150(3):905-907.
2. Eastham JA, Scardino PT. In: Walsh PC, Retik AB, Vaughan ED, et al, editor. Radical prostatectomy. Campbell's Urology 8th ed. Philadelphia: WB Saunders. 3080-3083.
3. Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Leibel SA, et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 2001;166:878-881.
4. Zelefsky MJ, Fuks Z, Happersett L, Lee HJ, Ling CC, Leibel SA, et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 2000;55(3):241-249.
5. Consensus conference. The management of clinically localized prostate cancer. JAMA 1987;258(19):2727-2730.
6. Epstein JI, Paull G, Eggleston JC, Walsh PC. Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup. J Urol 1986;136(4):837-839.
7. D'Amico AV, Whittington R, Kaplan I, Beard C, Schultz D, Coleman CN, et al. Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV. Int J Radiat Oncol Biol Phys 1997;39(2):335-340.
8. Kupelian P, Katcher J, Levin H, Zippe C, Suh J, Klein E, et al. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer:therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores. Cancer J Sci Am 1997;3(2):78-87.
9. Zelefsky MJ, Wallner KE, Ling CC, Raben A, Hollister T, Leibel SA, et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol 1999;17(2):517-522.
10. Adolfsson J, Steineck G, Whitmore WF Jr. Recent results of management of palpable clinically localized prostate cancer. Cancer 1993;72(2):310-322.
11. Peschel RE, Colberg JW. Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer. Lancet Oncol 2003;4(4):233-241.
12. Catalona WJ, Smith DS. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 1994;152(5 Pt 2):1837-1842.
13. Gibbons RP. Total prostatectomy for clinically localized prostate cancer: long-term surgical results and current morbidity. NCI Monogr 1988;7):123-126.
14. Babaian RJ, Zagars GK, Ayala AG. Radiation therapy of stage C prostate cancer: significance of Gleason grade to survival. Semin Urol 1990;8(4):225-231.
15. del Regato JA, Trailins AH, Pittman DD. Twenty years follow-up of patients with inoperable cancer of the prostate (stage C) treated by radiotherapy: report of a national cooperative study. Int J Radiat Oncol Biol Phys 1993;26(2):197-201.
16. Pilepich MV, Winter K, John MJ, Mesic JB, Sause W, Grignon D, et al. Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2001;50(5):1243-1252.
17. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys 1997;37(5):1035-1041.
18. Ritter MA, Messing EM, Shanahan TG, Potts S, Chappell RJ, Kinsella TJ. Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer. J Clin Oncol 1992;10(8):1208-1217.
19. Zagars GK, Sherman NE, Babaian RJ. Prostate-specific antigen and external beam radiation therapy in prostate cancer. Cancer 1991;67(2):412-420.
20. Critz FA, Williams WH, Holladay CT, Levinson AK, Benton JB, Shrake PD, et al. Post-treatment PSA < or = 0.2 ng/mL defines disease freedom after radiotherapy for prostate cancer using modern techniques. Urology 1999;54(6):968-971.
21. Hamilton AS, Stanford JL, Gilliland FD, Albertsen PC, Stephenson RA, Potosky AL, et al. Health outcomes after external-beam radiation therapy for clinically localized prostate cancer:results from the Prostate Cancer Outcomes Study. J Clin Oncol 2001;19(9):2517-2526.
22. Seymore CH, el-Mahdi AM, Schellhammer PF. The effect of prior transurethral resection of the prostate on post radiation urethral strictures and bladder neck contractures. Int J Radiat Oncol Biol Phys 1986;12(9):1597-1600.